+25.5%
GSK vs S
+4.5%
+21.0%
-18.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | S | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.7% | -2.3% | -0.4% | -2.9% |
| 7D | -4.2% | -5.8% | +1.6% | -4.6% |
| 30D | -7.5% | -9.2% | +1.7% | -8.0% |
| 3M | -3.3% | +23.4% | -26.6% | -2.0% |
| 6M | -9.3% | +36.9% | -46.3% | -7.6% |
| YTD | +1.6% | +29.5% | -27.9% | +3.4% |
| 1Y | +25.5% | +5.4% | +20.1% | +25.0% |
| All | +25.5% | +4.5% | +21.0% | +25.0% |
Cumulative growth
Daily Returns
Daily percentage return beside S.
Daily Out/Under-Performance
Portfolio return minus S return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × S return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded S wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling